Search for: "Bayer Health Care Pharmaceuticals Inc."
Results 81 - 100
of 102
Sort by Relevance
|
Sort by Date
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by… [read post]
3 Mar 2010, 5:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: Cozaar (Losartan), Hyzaar (Hydrochlorothiazide; Losartan) – US: Teva prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva v Kathleen Sebelius (FDA Law Blog) (SmartBrief) Nexavar (Sorafenib) - India: More on Bayer patent linkage - Supreme Court admits special leave petition filed by… [read post]
29 Dec 2009, 9:09 pm
Donabedian, PhD, MBA, Vice President, Strategic Alliances, US CEEDD, GSK Laura Pierce, Vice President, Alliance Management, Bayer HealthCare Pharmaceuticals Graham Brazier, VP, Therapeutic and Commercial Transactions, BMS Mark A. [read post]
29 Dec 2009, 9:09 pm
Donabedian, PhD, MBA, Vice President, Strategic Alliances, US CEEDD, GSK Laura Pierce, Vice President, Alliance Management, Bayer HealthCare Pharmaceuticals Graham Brazier, VP, Therapeutic and Commercial Transactions, BMS Mark A. [read post]
16 Dec 2009, 3:39 am
Potter about China’s Health Care Reform: ‘Do not forget cost of patent protection’ (IP Dragon) US: Ariad’s reply brief: Ariad Pharmaceuticals, Inc. v. [read post]
23 Nov 2009, 12:33 pm
Other drugs which are thought to cause health problems include birth control drugs, Yaz and Yasmin which were manufactured by Bayer Healthcare Pharmaceuticals, Inc. [read post]
27 Oct 2009, 7:04 am
Big health-care spenders in the third quarter of 2009 included Pfizer Inc.with $5.42 million; the American Hospital Association with $3.8 million, the American Medical Association with $3.95 million, Amgen Inc. ($3 million); Bayer Corp. ($2.45 million) and America’s Health Insurance Plans ($2.4 million). [read post]
22 Oct 2009, 7:00 am
At the forefront of this concern, the FDA issued a warning letter to Bayer Health Care Pharmaceuticals, Inc., the makers of the oral contraceptive Yaz, in 2008 stating that their commercials, "Not Gonna Take It" and "Balloons", are misleading due to widening the pill's abilities, exaggerating the effectiveness of Yaz, and undermining the serious risks connected to the drug's use. [read post]
1 Oct 2009, 2:14 am
Mylan Pharmaceuticals, 2008 WL 3540462 (N.D.W. [read post]
8 Jul 2009, 7:04 am
(Spicy IP) India: Novartis patent rejection by the IPAB: Accessing the decision (Spicy IP) (IAM) India: Likely corruption in the Indian health care sector – Public interest litigation over government shutdown of vaccine production plants to enter contracts with private sector (IP Osgoode) Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual… [read post]
12 Jun 2009, 10:49 am
Commissioner of Revenue of Massachusetts ; Geoffrey, Inc., v. [read post]
15 Apr 2009, 4:44 am
Houston County Health Care Authority v. [read post]
20 Mar 2009, 2:05 am
Sisters of Mercy Health System, Inc., 818 So.2d 833, 835 (La. [read post]
5 Feb 2009, 12:19 pm
Pfizer, Inc., 381 F. [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
23 May 2008, 1:03 am
: (Patent Baristas), Canada: Generic drug manufacturers urge Parliament to forfeit idea of new regulations delaying their ability to reproduce drugs: (Spicy IP), India: Indian generics and health activists having problem over patent titles: (Patent Circle), Europe: EPO to determine in June the fate of WARF stem cell patent application: (IPBiz), India: Choking the patients??? [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
